SEC Form 4 · accession 0001513162-17-000284
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis H Titterton Jr.
Director
Period of report
Oct 19, 2017
Accepted (ET)
Oct 23, 2017 · 5:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 19, 2017 | M | 2,400 | $0.67 | A | 834,544 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionF1 | $0.67 | Oct 19, 2017 | M | 2,400 | D | Nov 30, 2013 | Nov 30, 2017 | Common Stock | 2,400 | 0 | D |
Explanation of responses
- F1Right-To-Buy, pursuant to the ITUS Corporation 2010 Share Incentive Plan.